MYX 0.90% $4.39 mayne pharma group limited

Ann: Change of Director's Interest Notice, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,415 Posts.
    lightbulb Created with Sketch. 268
    I’ll believe it when I see it. I am with Roger
    what you’re just now saying we have had
    it all said numerous times before. Your
    confidence is not unlike many before you.
    Many who have now gone. Also had Mithra
    not mentioned shelf life and temp range of
    Myring we would be none the wiser. I believe
    those comments may well be part of the
    reason it hasn’t been approved with FDA.
    I don’t think they take too kindly to companies
    copying then trying to portray their Copy as
    superior to the original without spending
    $billions on R and D. Francois Fornieri the
    MD and major shareholder of Mithra is the
    person who stated those supposed facts and
    we all know where he is and why.
    Generics are just that and proven to be almost
    useless in the game of $ profits. Obviously
    it only sells on price. That is why you rarely
    receive the same product monthly from local
    Pharmacy here.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.39
Change
-0.040(0.90%)
Mkt cap ! $373.4M
Open High Low Value Volume
$4.44 $4.48 $4.22 $618.1K 142.5K

Buyers (Bids)

No. Vol. Price($)
1 693 $4.33
 

Sellers (Offers)

Price($) Vol. No.
$4.40 2133 2
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.